Non-Indigenous adults without risk conditions for pneumococcal disease are recommended to receive a pneumococcal conjugate vaccine at ≥70 years of age

A single dose of a pneumococcal conjugate vaccine (13vPCV, 15vPCV or 20vPCV) is recommended for all non-Indigenous adults at 70 years of age. There is no preference for either 13vPCV, 15vPCV or 20vPCV. It should be noted that 15vPCV and 20vPCV are anticipated to provide benefit against additional serotypes compared to 13vPCV.

Non-Indigenous adults aged ≥70 years who did not receive a dose of a pneumococcal conjugate vaccine at 70 years of age are recommended to receive a single catch-up dose of 13vPCV, 15vPCV or 20vPCV as soon as possible. See Infographic. Pneumococcal vaccination recommendations for people who have previously received a pneumococcal vaccine

Non-Indigenous adults aged ≥70 years who have previously received 23vPPV and have not already received a conjugate vaccine are recommended to receive a single dose of 13vPCV, 15vPCV or 20vPCV  at least 12 months after their last 23vPPV dose. See Infographic. Pneumococcal vaccination recommendations for people who have previously received a pneumococcal vaccine

Aboriginal and Torres Strait Islander adults aged ≥50 years, and all adults with one or more risk conditions for pneumococcal disease need extra doses. See:

• Aboriginal and Torres Strait Islander people
• People with medical risk factors
• Infographic. Pneumococcal vaccination for all Australians

13vPCV (Prevenar 13) is funded through the NIP for all non-Indigenous adults without risk conditions aged ≥70 years. For details see the National Immunisation Program Schedule.